Empiric red cell transfusion in asymptomatic preterm infants

Area of Science:

• Neonatal Medicine
• Pediatric Hematology
• Clinical Research

Background:

• Very low-birth-weight infants often require transfusions in neonatal intensive care units.
• The optimal threshold for red blood cell transfusion in asymptomatic neonates remains debated.
• Current practices vary regarding prophylactic transfusions to maintain specific hematocrit levels.

Purpose of the Study:

• To evaluate the impact of elective red blood cell transfusions on weight gain and hospitalization duration in asymptomatic very low-birth-weight infants.
• To compare morbidity criteria between transfused and non-transfused infants.
• To determine if empiric transfusion to a hematocrit greater than 0.35 l/l offers benefits outweighing transfusion risks.

Main Methods:

• Prospective randomized trial involving asymptomatic very low-birth-weight infants.
• Two groups were established: elective transfusion group (hematocrit > 0.35 l/l) and a control group (no transfusion).
• Exclusion criteria included subsequent non-elective transfusions due to clinical deterioration.

Main Results:

• Infants receiving elective transfusions demonstrated more rapid weight gain compared to the non-transfused group.
• No significant difference was observed in the duration of hospitalization between the two groups.
• Morbidity criteria, including patent ductus murmurs, apnea, and failure to thrive, were similar across both groups.

Conclusions:

• Empiric red blood cell transfusion to maintain a capillary hematocrit > 0.35 l/l in asymptomatic very low-birth-weight infants improves weight gain.
• The potential benefits of improved weight gain do not appear to outweigh the inherent risks of transfusion in the absence of clinical indications.
• Further research may be needed to refine transfusion guidelines for this vulnerable population.